Qualigen Therapeutics, Inc. (QLGN)
NASDAQ: QLGN · Real-Time Price · USD
4.870
-0.160 (-3.18%)
At close: Oct 8, 2025, 4:00 PM EDT
4.930
+0.060 (1.23%)
After-hours: Oct 8, 2025, 6:59 PM EDT
Qualigen Therapeutics Employees
Qualigen Therapeutics had 4 employees as of December 31, 2023. The number of employees decreased by 34 or -89.47% compared to the previous year.
Employees
4
Change (1Y)
-34
Growth (1Y)
-89.47%
Revenue / Employee
n/a
Profits / Employee
-$1,752,661
Market Cap
8.26M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 4 | -34 | -89.47% |
Dec 31, 2022 | 38 | -8 | -17.39% |
Dec 31, 2021 | 46 | 8 | 21.05% |
Dec 31, 2020 | 38 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
QLGN News
- 2 days ago - Qualigen Therapeutics (NASDAQ: QLGN) Announces Executives, Board of Directors Appointments and Auditor Transition - GlobeNewsWire
- 8 days ago - Univest Securities, LLC Announces Closing of $41 Million Strategic Investment in Client Qualigen Therapeutics (NASDAQ: QLGN) from Client Faraday Future (NASDAQ: FFAI) - GlobeNewsWire
- 8 days ago - Qualigen Therapeutics Announces Successful Closing of $41 Million PIPE Financing Led by Faraday Future, Accelerating New Business Transformation into Crypto - GlobeNewsWire
- 19 days ago - Faraday Future Announces Strategic $41 Million Investment in Qualigen Therapeutics, Inc. (NASDAQ: QLGN) f for Crypto Business Through PIPE Transaction - GlobeNewsWire
- 2 months ago - Qualigen Therapeutics Announces $4.5 Million Private Placement of Series A-3 Convertible Preferred Stock - GlobeNewsWire
- 5 months ago - Qualigen Therapeutics, Inc. receives expected notification of deficiency from Nasdaq related to delayed filing of quarterly report on Form 10-Q - GlobeNewsWire
- 5 months ago - Qualigen Therapeutics, Inc. Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Annual Report on Form 10-K - GlobeNewsWire
- 11 months ago - Univest Securities, LLC Announces Successful Closing of $5.1 Million Private Placement for Qualigen Therapeutics, Inc. (NASDAQ: QLGN) - GlobeNewsWire